At close: 3:54:30 PM GMT+8
Breakdown
12/31/2023
12/31/2022
12/31/2021
12/31/2020
Total Assets
847,786.000
1,008,348.000
1,041,655.000
1,129,523.000
Total Liabilities Net Minority Interest
552,203.000
498,773.000
361,429.000
142,512.000
Total Equity Gross Minority Interest
295,583.000
509,575.000
680,226.000
987,011.000
Total Capitalization
620,390.000
747,933.000
874,003.000
1,042,472.000
Common Stock Equity
295,583.000
509,575.000
680,226.000
987,011.000
Capital Lease Obligations
59,413.000
88,404.000
76,682.000
37,377.000
Net Tangible Assets
293,739.000
506,980.000
678,305.000
987,011.000
Working Capital
97,537.000
259,702.000
497,321.000
875,550.000
Invested Capital
686,978.000
778,354.000
879,003.000
1,047,472.000
Tangible Book Value
293,739.000
506,980.000
678,305.000
987,011.000
Total Debt
450,808.000
357,183.000
275,459.000
97,838.000
Net Debt
187,731.000
--
--
--
Share Issued
1,034,920.400
1,034,920.400
1,006,240.400
1,006,240.400
Ordinary Shares Number
1,034,920.400
1,034,920.400
1,006,240.400
1,006,240.400
12/31/2020 - 11/12/2019
Upgrade to begin using 40 years of financial statements and get so much more.
Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.
UpgradeRelated Tickers
6628.HK Transcenta Holding Limited
0.610
0.00%
6978.HK Immunotech Biopharm Ltd
2.550
-7.27%
1167.HK JACOBIO-B
1.310
-5.07%
1541.HK IMMUNEONCO-B
6.140
+1.99%
6990.HK Sichuan Kelun-Biotech Biopharmaceutical Co., Ltd.
179.400
-4.37%
1521.HK FRONTAGE
1.560
+3.31%
1530.HK 3SBIO
6.030
-1.95%
9926.HK Akeso, Inc.
61.750
-2.99%
MOLN Molecular Partners AG
5.41
-0.37%
OTLC Oncotelic Therapeutics, Inc.
0.0300
+1.01%